Data and corporate governance in pharma and digital health: A necessary regulatory convergence

Bibliographic Details
Main Authors: Carter, A, Meinert, E, Brindley, D
Format: Journal article
Language:English
Published: Mary Ann Liebert 2018
_version_ 1797070235000373248
author Carter, A
Meinert, E
Brindley, D
author_facet Carter, A
Meinert, E
Brindley, D
author_sort Carter, A
collection OXFORD
description
first_indexed 2024-03-06T22:36:00Z
format Journal article
id oxford-uuid:59eb0420-844c-41a6-b696-5d7f765e353e
institution University of Oxford
language English
last_indexed 2024-03-06T22:36:00Z
publishDate 2018
publisher Mary Ann Liebert
record_format dspace
spelling oxford-uuid:59eb0420-844c-41a6-b696-5d7f765e353e2022-03-26T17:12:36ZData and corporate governance in pharma and digital health: A necessary regulatory convergenceJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:59eb0420-844c-41a6-b696-5d7f765e353eEnglishSymplectic Elements at OxfordMary Ann Liebert2018Carter, AMeinert, EBrindley, D
spellingShingle Carter, A
Meinert, E
Brindley, D
Data and corporate governance in pharma and digital health: A necessary regulatory convergence
title Data and corporate governance in pharma and digital health: A necessary regulatory convergence
title_full Data and corporate governance in pharma and digital health: A necessary regulatory convergence
title_fullStr Data and corporate governance in pharma and digital health: A necessary regulatory convergence
title_full_unstemmed Data and corporate governance in pharma and digital health: A necessary regulatory convergence
title_short Data and corporate governance in pharma and digital health: A necessary regulatory convergence
title_sort data and corporate governance in pharma and digital health a necessary regulatory convergence
work_keys_str_mv AT cartera dataandcorporategovernanceinpharmaanddigitalhealthanecessaryregulatoryconvergence
AT meinerte dataandcorporategovernanceinpharmaanddigitalhealthanecessaryregulatoryconvergence
AT brindleyd dataandcorporategovernanceinpharmaanddigitalhealthanecessaryregulatoryconvergence